About Clot Connect

Clot Connect Background

What is Clot Connect?

Clot Connect®(clotconnect.org) is an information and outreach project of the University of North Carolina at Chapel Hill in the Hemophilia and Thrombosis Center.  Clot Connect's mission is to increase knowledge of blood clots, clotting disorders and anticoagulation by providing education and support resources for patients and health care professionals.

Clot Connect emerged in September 2010 from the observation that blood clot survivors face many unique challenges including risks associated with anticoagulant use (blood thinners), the development of post-thrombotic disorders and increased risks for future clots. Blood clot survivors and their families need information and support to manage the effects of a blood clot and to prevent future clots. It was also recognized that health care professionals need easier access to the latest treatment options and scientific research related to the diagnosis, care and management of patients with blood clots and clotting disorders. Additionally, it was known that although blood clots area a common health condition, there exists low public awareness.

 Clot Connect initiatives are targeted at:

  • Persons who have experienced a blood clot
  • Persons at high risk for developing a blood clot
  • Healthcare professionals who treat patient with or at risk for blood clots


Clot Connect's Mission

The mission of Clot Connect is to increase knowledge of thrombosis, thrombophilia and anticoagulation by providing connection to education and support resources for patients and health care professionals. 

 

A key role of Clot Connect is to serve as the go-to clearinghouse for reliable, clinically relevant thrombosis and anticoagulation information. 

 

For a detailed review of Clot Connect, including our past activity, current funding and future plans, please see our Annual Report.

 


Project LeadershipStephan Moll

Stephan Moll, MD; Medical Director

Clot Connect's medical direction is provided by Stephan Moll, MD;  Professor in the Department of Medicine and Division of Hematology-Oncology at the University of North Carolina at Chapel Hill.